Results 161 to 170 of about 14,358 (212)

Spatial proteomics of Alzheimer's disease-specific human microglial states. [PDF]

Nat Immunol
Mrdjen D, Cannon BJ, Amouzgar M, Kim Y, Liu C, Vijayaragavan K, Camacho C, Spence A, McCaffrey EF, Bharadwaj A, Tebaykin D, Bukhari S, Bosse M, Hartmann FJ, Kagel A, Oliveria JP, Yakabi K, Serrano GE, Corrada MM, Kawas CH, Tibshirani R, Beach TG, Corces MR, Greenleaf W, Angelo RM, Montine T, Bendall SC.   +26 more
europepmc   +1 more source

The comparison of Tc99m-pertechnetate/mibi subtraction and double phase Tc99m-Mibi techniques in parathyroid imaging

, 2000
Yararbaş Bilkay, Ülkem, Erinç, Rüya, Karapolat, İnanç, Kumanlıoğlu, Kamil   +3 more
openaire   +1 more source

Some of the next articles are maybe not open access.

Related searches:

To use MIBI or not to use MIBI? That is the question when assessing tumour cells

European Journal of Nuclear Medicine and Molecular Imaging, 2005
99mTc-sestamibi (MIBI) is a well-known tumour imaging agent. Its retention within tumour cell mitochondria is related to perfusion and to the magnitude of the electrical gradient, reflecting cell viability. Several internal cell factors modulate this uptake; for example, multidrug resistance membrane proteins (Pgp and MRP1) and anti-apoptotic BCl-2 ...
Jean-Luc, Moretti, Nathalie, Hauet, Meltem, Caglar, Olivier, Rebillard, Zeynep, Burak   +4 more
exaly   +4 more sources

Preparation of 186Re-MIBI complex for myocardial perfusion imaging as potential replacement of analogues 99mTc-MIBI complex

Journal of Radioanalytical and Nuclear Chemistry, 2012
The optimum conditions to label 2-methoxyisobutyl-isonitrile (MIBI) compound with pure 186Re as a stable contrast agent for myocardial perfusion imaging were investigated. Complexation of MIBI with 186Re was carried out using anhydrous stannous chloride, gentisic acid and 1 ml of 37 MBq 186ReO4 − at pH 2 in a boiling water bath for 30 ...
H. M. Talaat, A. A. El-Mohty
exaly   +2 more sources

Correlation between 99mTc-MIBI uptake and angiogenesis in MIBI-positive breast lesions

Nuclear Medicine and Biology, 2005
This study was undertaken to assess the correlation between the degree of accumulation and the washout of 99m technetium methoxyisobutylisonitrile ((99m)Tc-MIBI) and angiogenesis in MIBI-positive breast lesions. Twenty-eight patients (mean age, 51+/-11 years) with 31 breast lesions who underwent scintimammography were studied.
BEKİŞ, RECEP, Durak, H, Canda, T, Degirmenci, B, Aydin, A, Ozdogan, ÖZHAN   +5 more
openaire   +3 more sources

Incidental Pituitary Adenoma on MIBI Parathyroid Imaging

Clinical Nuclear Medicine, 2021
Abstract A 77-year-old man with a case of hyperthyroidism with high parathyroid hormone (41 pmol/L), low vitamin D, and normal thyroid-stimulating hormone. The SPECT/CT fused images confirmed the evidence of retrotracheal hyperdense mass approximately 1.0 cm of diameter below the lower pole of the right thyroid lobe with increased uptake ...
Jaber Abdulwahab, Asiri, Sami Ahmed, Kulaybi, Fatimah Ahmed, Daghas   +2 more
openaire   +2 more sources

Accumulation of99mTc-MIBI in bone marrow

Annals of Nuclear Medicine, 1996
99mTc-MIBI (Sestamibi) was originally developed for myocardial perfusion studies. The agent also may be used for the depiction and characterization of tumors. Performing such examinations has shown uptake in skeletal structures in several patients suggesting bone engagement of the disease which later was excluded.
C, Jonsson, H, Jacobsson
openaire   +2 more sources